Method of Optimizing the treatment of Proliferative Diseases Mediated by the Tyrosine Kinase Receptor KIT with Imatinib
US-2016045501-A1 · Feb 18, 2016 · US
Wehrle Elisabeth was listed as an assignee on 1 patent publication in 2016.
| Metric | Value |
|---|---|
| Company | Wehrle Elisabeth |
| Year | 2016 |
| Patents | 1 |
Representative publications for Wehrle Elisabeth in 2016.
Most common classification codes for Wehrle Elisabeth in 2016.
| CPC | Patents |
|---|---|
| A61K31/506 | 1 |
| A61P1/00 | 1 |
| A61P35/00 | 1 |
| A61P35/02 | 1 |
| A61P35/04 | 1 |
Navigate to parent entity pages.